BEAM – beam therapeutics inc. (US:NYSE)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

BEAM

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/12

04:12 pm

beam

Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference [Yahoo! Finance]

Low Report

Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference [Yahoo! Finance]

Report

11/12

04:01 pm

beam

Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference

Low Report

Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference

Report

11/7

02:28 pm

beam

Beam Therapeutics: Additional BEAM-101 And ESCAPE Tech Data At ASH 2024 Makes This A Watch [Seeking Alpha]

Low Report

Beam Therapeutics: Additional BEAM-101 And ESCAPE Tech Data At ASH 2024 Makes This A Watch [Seeking Alpha]

Report

11/7

08:36 am

beam

Beam Therapeutics Inc. (NASDAQ: BEAM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.

Low Report

Beam Therapeutics Inc. (NASDAQ: BEAM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.

Report

11/7

06:28 am

beam

Beam Therapeutics upgraded to Outperform from Market Perform at Leerink [Yahoo! Finance]

Low Report

Beam Therapeutics upgraded to Outperform from Market Perform at Leerink [Yahoo! Finance]

Report

11/7

06:22 am

beam

Beam Therapeutics Inc. (NASDAQ: BEAM) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.

Medium Report

Beam Therapeutics Inc. (NASDAQ: BEAM) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.

Report

11/6

01:26 pm

beam

Beam Therapeutics' Q3 Earnings & Revenues Fall Shy of Estimates [Yahoo! Finance]

Low Report

Beam Therapeutics' Q3 Earnings & Revenues Fall Shy of Estimates [Yahoo! Finance]

Report

11/6

11:05 am

beam

Beam Therapeutics Inc. (NASDAQ: BEAM) had its price target lowered by analysts at Royal Bank of Canada from $27.00 to $24.00. They now have a "sector perform" rating on the stock.

Low Report

Beam Therapeutics Inc. (NASDAQ: BEAM) had its price target lowered by analysts at Royal Bank of Canada from $27.00 to $24.00. They now have a "sector perform" rating on the stock.

Report

Date

Time

Symbol

Company Name

Action

%Chg

11/5/2024

06:30 am

beam

beam therapeutics inc.

MISS Report

-1.8%

beam therapeutics inc.

Report

5/7/2024

06:30 am

beam

beam therapeutics inc.

BEAT Report

-2.0%

beam therapeutics inc.

Report

2/27/2024

06:30 am

beam

beam therapeutics inc.

BEAT Report

25.9%

beam therapeutics inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

11/7

08:36 am

Reiterates

Buy

HC Wainwright

Low

Report

-1.1%

Report

11/6

10:58 am

Maintains

Sector Perform

RBC Capital

Low

Report

-0.1%

Report

11/6

10:58 am

Maintains

Sector Perform

RBC Capital

Low

Report

-0.1%

Report

11/6

07:32 am

Upgrades

Market Perform

Outperform

Leerink Partners

Medium

Report

6.5%

Report

11/6

07:26 am

Upgrades

Market Perform

Outperform

Leerink Partners

Medium

Report

6.7%

Report

11/5

06:24 pm

Reiterates

Outperform

Wedbush

High

Report

11.1%

Report

11/5

06:24 pm

Reiterates

Outperform

Wedbush

High

Report

11.1%

Report

10/16

10:28 am

Initiates

Sector Perform

Scotiabank

Low

Report

0.5%

Report

Date

Time

Symbol

Headline

Impact

11/12

09:51 am

beam

Form SC 13G/A Beam Therapeutics Inc. Filed by: FMR LLC

Medium Report

Form SC 13G/A Beam Therapeutics Inc. Filed by: FMR LLC

Report

11/8

04:11 pm

beam

Form 4 Beam Therapeutics Inc. For: Nov 06 Filed by: Ciaramella Giuseppe

High Report

Form 4 Beam Therapeutics Inc. For: Nov 06 Filed by: Ciaramella Giuseppe

Report

11/8

02:18 pm

beam

Form SC 13G/A Beam Therapeutics Inc. Filed by: BlackRock, Inc.

Low Report

Form SC 13G/A Beam Therapeutics Inc. Filed by: BlackRock, Inc.

Report

11/7

09:56 am

beam

Form SC 13G/A Beam Therapeutics Inc. Filed by: Farallon Capital Partners, L.P.

Low Report

Form SC 13G/A Beam Therapeutics Inc. Filed by: Farallon Capital Partners, L.P.

Report

11/5

09:06 am

beam

Form 10-Q Beam Therapeutics Inc. For: Sep 30

High Report

Form 10-Q Beam Therapeutics Inc. For: Sep 30

Report

11/5

09:00 am

beam